Cargando…

P1429: IN VITRO COMPARISON OF THE EFFECTS OF INCLACUMAB VS CRIZANLIZUMAB ON REDUCING ENDOTHELIAL ADHESION OF RED BLOOD CELLS IN STANDARDIZED MICROFLUIDIC PLATFORM

Detalles Bibliográficos
Autores principales: Federici, Chiara, Sertel, Seniye, Braxton, Samantha, Combs, Gabrielle, Sphen, Madelyn, Ophein, Kara, Kovshovik, Pavel, Zak, John, Geng, Xin, Gurkan, Umut
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430623/
http://dx.doi.org/10.1097/01.HS9.0000972600.79286.5a
_version_ 1785091010455404544
author Federici, Chiara
Sertel, Seniye
Braxton, Samantha
Combs, Gabrielle
Sphen, Madelyn
Ophein, Kara
Kovshovik, Pavel
Zak, John
Geng, Xin
Gurkan, Umut
author_facet Federici, Chiara
Sertel, Seniye
Braxton, Samantha
Combs, Gabrielle
Sphen, Madelyn
Ophein, Kara
Kovshovik, Pavel
Zak, John
Geng, Xin
Gurkan, Umut
author_sort Federici, Chiara
collection PubMed
description
format Online
Article
Text
id pubmed-10430623
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104306232023-08-17 P1429: IN VITRO COMPARISON OF THE EFFECTS OF INCLACUMAB VS CRIZANLIZUMAB ON REDUCING ENDOTHELIAL ADHESION OF RED BLOOD CELLS IN STANDARDIZED MICROFLUIDIC PLATFORM Federici, Chiara Sertel, Seniye Braxton, Samantha Combs, Gabrielle Sphen, Madelyn Ophein, Kara Kovshovik, Pavel Zak, John Geng, Xin Gurkan, Umut Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430623/ http://dx.doi.org/10.1097/01.HS9.0000972600.79286.5a Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Federici, Chiara
Sertel, Seniye
Braxton, Samantha
Combs, Gabrielle
Sphen, Madelyn
Ophein, Kara
Kovshovik, Pavel
Zak, John
Geng, Xin
Gurkan, Umut
P1429: IN VITRO COMPARISON OF THE EFFECTS OF INCLACUMAB VS CRIZANLIZUMAB ON REDUCING ENDOTHELIAL ADHESION OF RED BLOOD CELLS IN STANDARDIZED MICROFLUIDIC PLATFORM
title P1429: IN VITRO COMPARISON OF THE EFFECTS OF INCLACUMAB VS CRIZANLIZUMAB ON REDUCING ENDOTHELIAL ADHESION OF RED BLOOD CELLS IN STANDARDIZED MICROFLUIDIC PLATFORM
title_full P1429: IN VITRO COMPARISON OF THE EFFECTS OF INCLACUMAB VS CRIZANLIZUMAB ON REDUCING ENDOTHELIAL ADHESION OF RED BLOOD CELLS IN STANDARDIZED MICROFLUIDIC PLATFORM
title_fullStr P1429: IN VITRO COMPARISON OF THE EFFECTS OF INCLACUMAB VS CRIZANLIZUMAB ON REDUCING ENDOTHELIAL ADHESION OF RED BLOOD CELLS IN STANDARDIZED MICROFLUIDIC PLATFORM
title_full_unstemmed P1429: IN VITRO COMPARISON OF THE EFFECTS OF INCLACUMAB VS CRIZANLIZUMAB ON REDUCING ENDOTHELIAL ADHESION OF RED BLOOD CELLS IN STANDARDIZED MICROFLUIDIC PLATFORM
title_short P1429: IN VITRO COMPARISON OF THE EFFECTS OF INCLACUMAB VS CRIZANLIZUMAB ON REDUCING ENDOTHELIAL ADHESION OF RED BLOOD CELLS IN STANDARDIZED MICROFLUIDIC PLATFORM
title_sort p1429: in vitro comparison of the effects of inclacumab vs crizanlizumab on reducing endothelial adhesion of red blood cells in standardized microfluidic platform
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430623/
http://dx.doi.org/10.1097/01.HS9.0000972600.79286.5a
work_keys_str_mv AT federicichiara p1429invitrocomparisonoftheeffectsofinclacumabvscrizanlizumabonreducingendothelialadhesionofredbloodcellsinstandardizedmicrofluidicplatform
AT sertelseniye p1429invitrocomparisonoftheeffectsofinclacumabvscrizanlizumabonreducingendothelialadhesionofredbloodcellsinstandardizedmicrofluidicplatform
AT braxtonsamantha p1429invitrocomparisonoftheeffectsofinclacumabvscrizanlizumabonreducingendothelialadhesionofredbloodcellsinstandardizedmicrofluidicplatform
AT combsgabrielle p1429invitrocomparisonoftheeffectsofinclacumabvscrizanlizumabonreducingendothelialadhesionofredbloodcellsinstandardizedmicrofluidicplatform
AT sphenmadelyn p1429invitrocomparisonoftheeffectsofinclacumabvscrizanlizumabonreducingendothelialadhesionofredbloodcellsinstandardizedmicrofluidicplatform
AT opheinkara p1429invitrocomparisonoftheeffectsofinclacumabvscrizanlizumabonreducingendothelialadhesionofredbloodcellsinstandardizedmicrofluidicplatform
AT kovshovikpavel p1429invitrocomparisonoftheeffectsofinclacumabvscrizanlizumabonreducingendothelialadhesionofredbloodcellsinstandardizedmicrofluidicplatform
AT zakjohn p1429invitrocomparisonoftheeffectsofinclacumabvscrizanlizumabonreducingendothelialadhesionofredbloodcellsinstandardizedmicrofluidicplatform
AT gengxin p1429invitrocomparisonoftheeffectsofinclacumabvscrizanlizumabonreducingendothelialadhesionofredbloodcellsinstandardizedmicrofluidicplatform
AT gurkanumut p1429invitrocomparisonoftheeffectsofinclacumabvscrizanlizumabonreducingendothelialadhesionofredbloodcellsinstandardizedmicrofluidicplatform